Cargando…

Acute Intravenous Injection of Serelaxin (Recombinant Human Relaxin‐2) Causes Rapid and Sustained Bradykinin‐Mediated Vasorelaxation

BACKGROUND: A recent clinical trial (RELAXin in Acute Heart Failure [RELAX‐AHF]) demonstrated that 48 hours of continuous intravenous infusion of the vasorelaxant peptide serelaxin (recombinant human relaxin‐2) to patients with acute heart failure reduced cardiovascular mortality at 180 days. The pe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leo, Chen Huei, Jelinic, Maria, Parkington, Helena C., Tare, Marianne, Parry, Laura J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959707/ https://www.ncbi.nlm.nih.gov/pubmed/24584737 http://dx.doi.org/10.1161/JAHA.113.000493

Ejemplares similares

A Vasoactive Role for Endogenous Relaxin in Mesenteric Arteries of Male Mice
por: Leo, Chen Huei, et al.
Publicado: (2014)

Relaxin Deficiency Leads to Uterine Artery Dysfunction During Pregnancy in Mice
por: Marshall, Sarah A., et al.
Publicado: (2018)

Protection from cigarette smoke‐induced vascular injury by recombinant human relaxin‐2 (serelaxin)
por: Pini, Alessandro, et al.
Publicado: (2016)

Serelaxin, recombinant human relaxin-2, for heart failure patients: A systematic review and meta-analysis
por: Yu, Ling, et al.
Publicado: (2018)

Serelaxin Elicits Bronchodilation and Enhances β-Adrenoceptor-Mediated Airway Relaxation
por: Lam, Maggie, et al.
Publicado: (2016)

Porcine Relaxin but Not Serelaxin Shows Residual Bioactivity after In Vitro Simulated Intestinal Digestion—Clues for the Development of New Relaxin Peptide Agonists Suitable for Oral Delivery
por: Pacini, Lorenzo, et al.
Publicado: (2022)

Effects of human relaxin-2 (serelaxin) on hypoxic pulmonary vasoconstriction during acute hypoxia in a sheep model
por: Schiffner, René, et al.
Publicado: (2018)

Serelaxin Treatment Reduces Oxidative Stress and Increases Aldehyde Dehydrogenase-2 to Attenuate Nitrate Tolerance
por: Leo, Chen Huei, et al.
Publicado: (2017)

Relaxin as a Therapeutic Target for the Cardiovascular Complications of Diabetes
por: Ng, Hooi Hooi, et al.
Publicado: (2018)

Serelaxin treatment reverses vascular dysfunction and left ventricular hypertrophy in a mouse model of Type 1 diabetes
por: Ng, Hooi Hooi, et al.
Publicado: (2017)

Altered Cerebral Blood Flow and Potential Neuroprotective Effect of Human Relaxin-2 (Serelaxin) During Hypoxia or Severe Hypovolemia in a Sheep Model
por: Schiffner, René, et al.
Publicado: (2020)

Chronic Exposure to Cigarette Smoke Affects the Ileum and Colon of Guinea Pigs Differently. Relaxin (RLX-2, Serelaxin) Prevents Most Local Damage
por: Traini, Chiara, et al.
Publicado: (2022)

Human Relaxin-2 (Serelaxin) Attenuates Oxidative Stress in Cardiac Muscle Cells Exposed In Vitro to Hypoxia–Reoxygenation. Evidence for the Involvement of Reduced Glutathione Up-Regulation
por: Nistri, Silvia, et al.
Publicado: (2020)

Differences in the renal antifibrotic signaling of serelaxin and zaprinast
por: Wetzl, Veronika, et al.
Publicado: (2015)

Relaxin'
Publicado: (1983)

Relaxin
por: DeCherney, Alan H.
Publicado: (1982)

Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis
por: Bennett, Robert G, et al.
Publicado: (2017)

Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats
por: Wang, Dong, et al.
Publicado: (2017)

Serelaxin Alleviates Fibrosis in Thyroid-Associated Ophthalmopathy via the Notch Pathway
por: Sun, Anqi, et al.
Publicado: (2023)

Involvement of bradykinin and bradykinin B1 receptor in patients with endometriosis
por: Meng, Xin, et al.
Publicado: (2021)

Disconnect between the effects of serelaxin on renal function and outcome in acute heart failure
por: Beldhuis, I. E., et al.
Publicado: (2023)

Pharmacological effects of recombinant human tissue kallikrein on bradykinin B(2) receptors
por: Charest-Morin, Xavier, et al.
Publicado: (2015)

Bradykinin receptor expression and bradykinin-mediated sensitization of human sensory neurons
por: Yi, Jiwon, et al.
Publicado: (2023)

Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF
por: Metra, Marco, et al.
Publicado: (2013)

The effect of relaxin on the musculoskeletal system
por: Dehghan, F, et al.
Publicado: (2014)

Neprilysin Inhibitors and Bradykinin
por: Campbell, Duncan J.
Publicado: (2018)

Characterizing relaxin receptor expression and exploring relaxin’s effect on tissue remodeling/fibrosis in the human bladder
por: Diaz, Edward C., et al.
Publicado: (2020)

Potentiation of bradykinin actions by analogues of the bradykinin potentiating nonapeptide BPP(9α)
por: Mueller, Sylvia, et al.
Publicado: (2005)

Serelaxin for the treatment of acute heart failure: a review with a focus on end-organ protection
por: Díez, Javier, et al.
Publicado: (2016)

Effects of serelaxin in acute heart failure patients with renal impairment: results from RELAX-AHF
por: Liu, Licette C. Y., et al.
Publicado: (2016)

Involvement of Cyclic Guanosine Monophosphate-Dependent Protein Kinase I in Renal Antifibrotic Effects of Serelaxin
por: Wetzl, Veronika, et al.
Publicado: (2016)

Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy
por: Nonhoff, Justus, et al.
Publicado: (2017)

A phase 2 randomised controlled trial of serelaxin to lower portal pressure in cirrhosis (STOPP)
por: Gifford, Fiona J., et al.
Publicado: (2020)

Serelaxin alleviates cardiac fibrosis through inhibiting endothelial-to-mesenchymal transition via RXFP1
por: Wilhelmi, Tim, et al.
Publicado: (2020)

Chronic low alcohol intake during pregnancy programs sex-specific cardiovascular deficits in rats
por: Walton, Sarah L., et al.
Publicado: (2019)

Evolution of the relaxin-like peptide family
por: Wilkinson, Tracey N, et al.
Publicado: (2005)

Structural relationships and vasorelaxant activity of monoterpenes
por: Cardoso Lima, Tamires, et al.
Publicado: (2012)

Vasorelaxant effect of Prunus yedoensis bark
por: Lee, Kyungjin, et al.
Publicado: (2013)

Hydrogen Sulfide and Endothelium-Dependent Vasorelaxation
por: Bełtowski, Jerzy, et al.
Publicado: (2014)

Distinct activation modes of the Relaxin Family Peptide Receptor 2 in response to insulin-like peptide 3 and relaxin
por: Bruell, Shoni, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v0ntcetf0dknavljgle6l7qcku